Oddo Bhf Asset Management Sas Alnylam Pharmaceuticals, Inc. Transaction History
Oddo Bhf Asset Management Sas
- $2.39 Trillion
- Q1 2025
A detailed history of Oddo Bhf Asset Management Sas transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Oddo Bhf Asset Management Sas holds 19,821 shares of ALNY stock, worth $5.36 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
19,821Holding current value
$5.36 Million% of portfolio
0.22%Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
684Shares Held
109MCall Options Held
856KPut Options Held
752K-
Capital World Investors Los Angeles, CA16.7MShares$4.53 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$3.53 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.58 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$1.93 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.18 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.2B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...